Cost-effectiveness analysis of micafungin versus caspofungin for treatment of systemic Candida infections in the UK

By Sidhu M. K.   van Engen A. K.   Kleintjens J.   Schoeman O.   Palazzo M.  

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 2049-2059

Informa Healthcare

Access to resources Recommend Favorite

De-escalation from micafungin is a cost-effective alternative to traditional escalation from fluconazole in the treatment of patients with systemic Candida infections

By Masterton Robert G.   Casamayor Montserrat   Musingarimi Primrose   van Engen Anke   Zinck Raymund   Odufowora-Sita Olatunji   Odeyemi Isaac A. O.  

Journal of Medical Economics, Vol. 16, Iss. 11, 2013-11 ,pp. : 1344-1356

Informa Healthcare

Access to resources Recommend Favorite

Reduced activity of Candida detachment factors in the saliva of the elderly

By Kamagata-Kiyoura Yusuke   Abe Shigeru   Yamaguchi Hideyo   Nitta Toshimasa  

Journal of Infection and Chemotherapy, Vol. 10, Iss. 1, 2004-02 ,pp. : 59-61

Springer Publishing Company

Access to resources Recommend Favorite

Utilization and dosage pattern of echinocandins for treatment of fungal infections in US hospital practice*

By Chandwani Sheenu   Wentworth Chuck   Burke Thomas A.   Patterson Thomas F.  

Current Medical Research and Opinion, Vol. 25, Iss. 2, 2009-02 ,pp. : 385-393

Informa Healthcare

Access to resources Recommend Favorite

Use of CHROMagar medium in the differentiation of Candida species: is it cost-effective in developing countries?

By Iyampillai T.   Michael J. S.   Mathai E.   Mathews M. S.  

Annals of Tropical Medicine and Parasitology, Vol. 98, Iss. 3, 2004-04 ,pp. : 279-282

Maney Publishing

Access to resources Recommend Favorite